Lactitol Patent Expiration

Lactitol is Used for treating chronic idiopathic constipation in adult patients. It was first introduced by Braintree Laboratories Inc in its drug Pizensy on Feb 12, 2020.


Lactitol Patents

Given below is the list of patents protecting Lactitol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Pizensy US10806743 Method of administering lactitol to reduce plasma concentration of lactitol May 12, 2037 Braintree Labs



Lactitol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List